Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» J&J’s Doxil/Caelyx shortages affect ovarian cancer trials
J&J’s Doxil/Caelyx shortages affect ovarian cancer trials
J&J’s Doxil/Caelyx shortages affect ovarian cancer trials
Submitted by
admin
on October 19, 2011 - 12:04pm
Source:
FT.com
News Tags:
JNJ
drug shortages
Doxil
Caelyx
ovarian cancer
Headline:
J&J’s Doxil/Caelyx shortages affect ovarian cancer trials
Do Not Allow Advertisers to Use My Personal information
